Experts from one of the leading stem cell transplant centers, the Fred Hutchinson Cancer Research Center at the University of Washington, have reported a case of ciHHV6A reactivation in a patient who developed CNS dysfunction and HHV-6A encephalitis after receiving a hematopoietic cell transplant (HCT). The authors of the study believe these findings are best explained by ciHHV-6A reactivation, and emphasize the need for large multicenter collaborations to determine the impact of ciHHV-6 on patient outcomes. READ MORE